158 related articles for article (PubMed ID: 7553685)
41. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
[TBL] [Abstract][Full Text] [Related]
42. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
43. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
Lando PA; Hedlund G; Dohlsten M; Kalland T
Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxic T lymphocyte-dependent tumor growth inhibition by a vascular endothelial growth factor-superantigen conjugate.
Sun Q; Jiang S; Han B; Sun T; Li Z; Zhao L; Gao Q; Sun J
Biochem Biophys Res Commun; 2012 Nov; 427(4):711-7. PubMed ID: 23036194
[TBL] [Abstract][Full Text] [Related]
45. In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein.
Ma W; Yu H; Wang Q; Bao J; Yan J; Jin H
Cancer Immunol Immunother; 2004 Feb; 53(2):118-24. PubMed ID: 14574492
[TBL] [Abstract][Full Text] [Related]
46. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
[TBL] [Abstract][Full Text] [Related]
47. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
[TBL] [Abstract][Full Text] [Related]
48. Immune response to staphylococcal superantigens.
Krakauer T
Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
[TBL] [Abstract][Full Text] [Related]
49. Naptumomab estafenatox, an engineered antibody-superantigen fusion protein with low toxicity and reduced antigenicity.
Forsberg G; Skartved NJ; Wallén-Ohman M; Nyhlén HC; Behm K; Hedlund G; Nederman T
J Immunother; 2010 Jun; 33(5):492-9. PubMed ID: 20463598
[TBL] [Abstract][Full Text] [Related]
50. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
52. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
D'Orazio JA; Stein-Streilein J
Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
[TBL] [Abstract][Full Text] [Related]
53. Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.
Pulaski BA; Terman DS; Khan S; Muller E; Ostrand-Rosenberg S
Cancer Res; 2000 May; 60(10):2710-5. PubMed ID: 10825145
[TBL] [Abstract][Full Text] [Related]
54. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A.
Abrahmsén L; Dohlsten M; Segrén S; Björk P; Jonsson E; Kalland T
EMBO J; 1995 Jul; 14(13):2978-86. PubMed ID: 7542584
[TBL] [Abstract][Full Text] [Related]
55. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
[TBL] [Abstract][Full Text] [Related]
56. Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.
Xiang R; Lode HN; Dolman CS; Dreier T; Varki NM; Qian X; Lo KM; Lan Y; Super M; Gillies SD; Reisfeld RA
Cancer Res; 1997 Nov; 57(21):4948-55. PubMed ID: 9354462
[TBL] [Abstract][Full Text] [Related]
57. Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.
Litton MJ; Dohlsten M; Hansson J; Rosendahl A; Ohlsson L; Kalland T; Andersson J; Andersson U
Am J Pathol; 1997 May; 150(5):1607-18. PubMed ID: 9137087
[TBL] [Abstract][Full Text] [Related]
58. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
59. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
Moseley AB; Huston DP
J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
